Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

29 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Anti-C-carbohydrate antibodies after pneumococcal vaccination.
Pedersen FK, Henrichsen J, Sørensen US, Nielsen JL. Pedersen FK, et al. Acta Pathol Microbiol Immunol Scand C. 1982 Dec;90(6):353-5. doi: 10.1111/j.1699-0463.1982.tb01462.x. Acta Pathol Microbiol Immunol Scand C. 1982. PMID: 7170960
Curvature of synthetic and natural surfaces is an important target feature in classical pathway complement activation.
Pedersen MB, Zhou X, Larsen EK, Sørensen US, Kjems J, Nygaard JV, Nyengaard JR, Meyer RL, Boesen T, Vorup-Jensen T. Pedersen MB, et al. J Immunol. 2010 Feb 15;184(4):1931-45. doi: 10.4049/jimmunol.0902214. Epub 2010 Jan 6. J Immunol. 2010. PMID: 20053940
Prevention of invasive bacterial diseases by immunization with polysaccharide-protein conjugates.
Robbins JB, Schneerson R, Szu SC, Fattom A, Yang Y, Lagergard T, Chu C, Sørensen US. Robbins JB, et al. Curr Top Microbiol Immunol. 1989;146:169-80. doi: 10.1007/978-3-642-74529-4_18. Curr Top Microbiol Immunol. 1989. PMID: 2659266 Review.
Structural determinants for AMPA agonist activity of aryl or heteroaryl substituted AMPA analogues. Synthesis and pharmacology.
Sørensen US, Falch E, Stensbøl TB, Jaroszewski JW, Madsen U, Krogsgaard-Larsen P. Sørensen US, et al. Arch Pharm (Weinheim). 2001 Feb;334(2):62-8. doi: 10.1002/1521-4184(200102)334:2<62::aid-ardp62>3.0.co;2-g. Arch Pharm (Weinheim). 2001. PMID: 11268776
Inhibition of KCa2 Channels Decreased the Risk of Ventricular Arrhythmia in the Guinea Pig Heart During Induced Hypokalemia.
Diness JG, Abildgaard L, Bomholtz SH, Skarsfeldt MA, Edvardsson N, Sørensen US, Grunnet M, Bentzen BH. Diness JG, et al. Among authors: sorensen us. Front Pharmacol. 2020 May 20;11:749. doi: 10.3389/fphar.2020.00749. eCollection 2020. Front Pharmacol. 2020. PMID: 32508659 Free PMC article.
Mechanisms of Action of the KCa2-Negative Modulator AP30663, a Novel Compound in Development for Treatment of Atrial Fibrillation in Man.
Bentzen BH, Bomholtz SH, Simó-Vicens R, Folkersen L, Abildgaard L, Speerschneider T, Muthukumarasamy KM, Edvardsson N, Sørensen US, Grunnet M, Diness JG. Bentzen BH, et al. Among authors: sorensen us. Front Pharmacol. 2020 May 6;11:610. doi: 10.3389/fphar.2020.00610. eCollection 2020. Front Pharmacol. 2020. PMID: 32477117 Free PMC article.
The KCa2 Channel Inhibitor AP30663 Selectively Increases Atrial Refractoriness, Converts Vernakalant-Resistant Atrial Fibrillation and Prevents Its Reinduction in Conscious Pigs.
Diness JG, Kirchhoff JE, Speerschneider T, Abildgaard L, Edvardsson N, Sørensen US, Grunnet M, Bentzen BH. Diness JG, et al. Among authors: sorensen us. Front Pharmacol. 2020 Feb 28;11:159. doi: 10.3389/fphar.2020.00159. eCollection 2020. Front Pharmacol. 2020. PMID: 32180722 Free PMC article.
29 results
Jump to page
Feedback